Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Bill promotes telemedicine across state lines

A bill introduced in the House of Representatives would allow Medicare providers using telehealth technologies to treat Medicare patients without the need to obtain multiple state licenses.

HHS: Reform saving consumers more than $1B

The Affordable Care Act saved 6.8 million consumers an estimated $1.2 billion on health insurance premiums in 2012 due to the "rate review" provision, according to a report released by the Department of Health & Human Services.

HIX federal data services hub completed

Federal health officials announced a major milestone for the health insurance exchanges, scheduled to open for enrollment on Oct. 1.

ACP: MU timeline is too aggressive

When it comes to the Meaningful Use incentive program, the American College of Physicians cautioned that the compliance timeline is overly aggressive and that the program’s objectives are too ambitious.

AMA toolkit prepares physicians for HIPAA compliance

With the HIPAA omnibus rule Sept. 23 compliance date just around the corner, the American Medical Association released free resources to prepare physicians for the new regulations that require extensive changes to existing privacy, security and breach notification requirements.

Target enters healthcare innovation fray

Another large retail chain is furthering its healthcare efforts. Target has unveiled the Simplicity Challenge, a nationwide search for innovative ideas to simplify healthcare.

Attend the first AMDIS Fall Symposium in Boston

For more information and to register, please visit the conference website.

HITPC: Committee approves FDASIA workgroup draft recommendations

The Heath IT Policy Committee approved a slew of recommendations presented by the FDA Safety and Innovation Act Workgroup at its meeting on Sept. 4.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.